7,533.75

-40.50

-0.53%

52,490.00

-8.00

-0.02%

27,723.75

-290.75

-1.04%

Russell 2000 Futures

2,827.80

-20.90

-0.73%

4.9380

+0.0740

+1.52%

21.60

+1.68

+8.51%

4,067.80

-46.70

-1.14%

73,733.21

-882.22

-1.18%

Crude Oil Dec 26

84.47

-2.38

-2.74%

US Private Equity

10,850.15

0.00

0.00%

NasdaqCM - Nasdaq Real Time Price USD

Intensity Therapeutics, Inc. (INTS)

3.1500 +0.1500 (+5.00%)

At close: November 9 at 4:00:01 PM EST

Loading Chart for INTS

Chart Range Bar

Interval:

In partnership with ChartIQ

Intensity (INTS) Q3 2026 Earnings Call Transcript

Intensity (INTS) Q3 2026 Earnings Call Transcript

Intensity Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update

Intensity Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update

Intensity Therapeutics to Announce Third Quarter 2026 Financial Results on November 5, 2026

Intensity Therapeutics to Announce Third Quarter 2026 Financial Results on November 5, 2026

Intensity Therapeutics, Inc. to Present INVINCIBLE-4 Neoadjuvant Triple-Negative Breast Cancer Study Data for the First Seven (7) Patients After INT230-6 Treatment (Cohort A) in an ePoster Presentation at the European Society of Medical Oncology (ESMO) Meeting

Intensity Therapeutics, Inc. to Present INVINCIBLE-4 Neoadjuvant Triple-Negative Breast Cancer Study Data for the First Seven (7) Patients After INT230-6 Treatment (Cohort A) in an ePoster Presentation at the European Society of Medical Oncology (ESMO) Meeting

Intensity Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Intensity Therapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Intensity Therapeutics (INTS) Q2 2026 Earnings Call Transcript

Intensity Therapeutics (INTS) Q2 2026 Earnings Call Transcript

Intensity Therapeutics to Announce Second Quarter 2026 Financial Results on August 11, 2026

Intensity Therapeutics to Announce Second Quarter 2026 Financial Results on August 11, 2026

Intensity Therapeutics Provides Mid-Year Update Highlighting Late-Stage Development Programs and Strategic Partnering Opportunities for INT230-6

Intensity Therapeutics Provides Mid-Year Update Highlighting Late-Stage Development Programs and Strategic Partnering Opportunities for INT230-6

Intensity Therapeutics Recognized with GHP Magazine's 2026 Healthcare & Pharmaceutical Award

Intensity Therapeutics Recognized with GHP Magazine's 2026 Healthcare & Pharmaceutical Award

Intensity Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

Intensity Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update

Intensity Therapeutics Inc. (INTS) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Intensity Therapeutics Inc. (INTS) Could Find a Support Soon, Here's Why You Should Buy the Stock Now

Mobilize your Website

View Site in Mobile | Classic

Share by: